Korean J Fam Pract.
2023 Dec;13(4):247-248. 10.21215/kjfp.2023.13.4.247.
[Correction] Recurrent Neural Network Based Drug Repurposing to Address SARS-CoV-2 (COVID-19), and the in vitro Antiviral Efficacy of Peroxisome Proliferator-Activated Receptors-Gamma Agonist
- Affiliations
-
- 1Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2549648
- DOI: http://doi.org/10.21215/kjfp.2023.13.4.247
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recurrent Neural Network Based Drug Repurposing to Address SARS-CoV-2 (COVID-19), and the in vitro Antiviral Efficacy of Peroxisome Proliferator-Activated Receptors-Gamma Agonist
- Antiviral Efficacy of Pralatrexate against SARS-CoV-2
- Peroxisome Proliferator-activated Receptors (PPARs) in Diabetic Nephropathy
- SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
- COVID-19 and Breastfeeding
